Cyclobenzaprine: positive opinion from EMA in Rapid Scientific Advice procedure as a possible anti-Covid-19 therapy

M-Squared Consulting, a consultancy company for life sciences companies in the management of pharmaceutical contracts, has received a first positive signal from EMA’s Pandemic Task Force in the Rapid Scientific Advice1 procedure for potential treatments for Covid-19 in the repositioning project for cyclobenzaprine, a drug for the treatment of acute musculoskeletal conditions. Cyclobenzaprine, based on preclinical scientific evidence, has…

thaipr.net

24 มี.ค. 65

Terran Biosciences announces licensing deal with Columbia University for exclusive worldwide rights to proprietary CNS biomarker software platform

Terran Biosciences, Inc. (“Terran”), a biotech platform company dedicated to the development of transformational therapeutics and technologies for neurological and psychiatric diseases, has entered into an agreement with Columbia University (“Columbia”) and the Research Foundation for Mental Hygiene (“RFMH”), to obtain worldwide exclusive rights to develop and commercialize Columbia’s proprietary CNS…

thaipr.net

17 มี.ค. 65

Terran Biosciences announces acquisition of a portfolio of novel CNS therapeutics from Concert Pharmaceuticals

Terran Biosciences (“Terran”), a biotech platform company dedicated to the development of transformational therapeutics for neurological and psychiatric diseases, has entered into an agreement with Concert Pharmaceuticals (“Concert”) to acquire a portfolio of Concert’s CNS therapeutics and accompanying intellectual property. These deuterated compounds represent next-generation therapeutics with applications across…

thaipr.net

14 มี.ค. 65

Gan & Lee Pharmaceuticals Begins First-In-Human Trial in U.S. for Investigational Drug, GZR18

Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee, stock code: 603087.SH), is pleased to announce the first subject has been dosed in our Phase I, double-blinded, randomized, placebo-controlled, sequential, single, ascending dose clinical study in the U.S. for the company’s investigational drug, GZR18. GZR18 is a glucagon-like peptide-1 receptor agonist (GLP-1RA) […]

thaipr.net

11 มี.ค. 65

Novavax Announces Launch of Global Vaccine Education Programs

–  ‘We Do Vaccines’ and ‘Know Our Vax’ are new educational efforts that provide information regarding vaccines –  Programs explain Novavax’ commitment to vaccine development and innovation Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the launch of its global unbranded ‘We…

thaipr.net

11 มี.ค. 65
1 87 88 89 90 91 139